West Pharmaceutical Services, Inc.West Pharmaceutical Services, Inc.West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪15.06 B‬EUR
‪475.94 M‬EUR
‪2.79 B‬EUR
‪71.46 M‬
Beta (1Y)
0.72
Employees (FY)
‪10.6 K‬
Change (1Y)
0
Revenue / Employee (1Y)
‪263.61 K‬EUR
Net income / Employee (1Y)
‪44.90 K‬EUR

About West Pharmaceutical Services, Inc.


CEO
Eric Mark Green
Headquarters
Exton
Founded
1923
ISIN
US9553061055
FIGI
BBG01TNY7ZF4
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. The Proprietary Products segment offers proprietary packaging, containment solutions and drug delivery products, along with analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Check out other big names from the same industry as 1WST.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Frequently Asked Questions


The current price of 1WST is 213.9 EUR — it has increased by 0.24% in the past 24 hours. Watch West Pharmaceutical Services, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange West Pharmaceutical Services, Inc. stocks are traded under the ticker 1WST.
1WST stock has fallen by −1.46% compared to the previous week, the month change is a −3.74% fall, over the last year West Pharmaceutical Services, Inc. has showed a 14.85% increase.
We've gathered analysts' opinions on West Pharmaceutical Services, Inc. future price: according to them, 1WST price has a max estimate of 297.96 EUR and a min estimate of 221.34 EUR. Watch 1WST chart and read a more detailed West Pharmaceutical Services, Inc. stock forecast: see what analysts think of West Pharmaceutical Services, Inc. and suggest that you do with its stocks.
1WST reached its all-time high on Jul 25, 2025 with the price of 248.3 EUR, and its all-time low was 180.7 EUR and was reached on May 23, 2025. View more price dynamics on 1WST chart.
See other stocks reaching their highest and lowest prices.
1WST stock is 2.48% volatile and has beta coefficient of 0.72. Track West Pharmaceutical Services, Inc. stock price on the chart and check out the list of the most volatile stocks — is West Pharmaceutical Services, Inc. there?
Today West Pharmaceutical Services, Inc. has the market capitalization of ‪15.35 B‬, it has decreased by −0.65% over the last week.
Yes, you can track West Pharmaceutical Services, Inc. financials in yearly and quarterly reports right on TradingView.
West Pharmaceutical Services, Inc. is going to release the next earnings report on Oct 23, 2025. Keep track of upcoming events with our Earnings Calendar.
1WST earnings for the last quarter are 1.56 EUR per share, whereas the estimation was 1.28 EUR resulting in a 21.92% surprise. The estimated earnings for the next quarter are 1.44 EUR per share. See more details about West Pharmaceutical Services, Inc. earnings.
West Pharmaceutical Services, Inc. revenue for the last quarter amounts to ‪650.68 M‬ EUR, despite the estimated figure of ‪616.38 M‬ EUR. In the next quarter, revenue is expected to reach ‪674.29 M‬ EUR.
1WST net income for the last quarter is ‪111.89 M‬ EUR, while the quarter before that showed ‪83.01 M‬ EUR of net income which accounts for 34.79% change. Track more West Pharmaceutical Services, Inc. financial stats to get the full picture.
Yes, 1WST dividends are paid quarterly. The last dividend per share was 0.18 EUR. As of today, Dividend Yield (TTM)% is 0.34%. Tracking West Pharmaceutical Services, Inc. dividends might help you take more informed decisions.
West Pharmaceutical Services, Inc. dividend yield was 0.25% in 2024, and payout ratio reached 12.27%. The year before the numbers were 0.22% and 9.90% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 4, 2025, the company has ‪10.6 K‬ employees. See our rating of the largest employees — is West Pharmaceutical Services, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. West Pharmaceutical Services, Inc. EBITDA is ‪668.34 M‬ EUR, and current EBITDA margin is 25.93%. See more stats in West Pharmaceutical Services, Inc. financial statements.
Like other stocks, 1WST shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade West Pharmaceutical Services, Inc. stock right from TradingView charts — choose your broker and connect to your account.